This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting central nervous system disorders, such as anxiety, depression, and neurodegenerative diseases. Its structural features, including the trifluoromethoxy group, enhance the bioavailability and metabolic stability of the resulting drugs. Additionally, it is explored in the development of receptor-specific ligands, aiding in the study of biochemical pathways and potential therapeutic interventions. Its applications extend to preclinical studies, where it is used to evaluate efficacy and safety profiles of new medications.